Kristin R. Wildsmith
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, S100 Proteins and Annexins
Most-Cited Works
- → Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates(2014)359 cited
- → Evidence for impaired amyloid β clearance in Alzheimer's disease(2013)227 cited
- → Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease(2022)178 cited
- → Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease(2018)170 cited
- → Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF(2015)168 cited
- → Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics(2014)150 cited
- → Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)(2018)149 cited
- → Characterization of alkylacyl, alk‐1‐enylacyl and lyso subclasses of glycerophosphocholine by tandem quadrupole mass spectrometry with electrospray ionization(2003)116 cited
- → Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease(2021)106 cited
- → Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology(2019)105 cited